For those with in-house path labs, we just got an important update from DermCoder (www.dermcoder.com).

Medicare now expects you to use the biopsy date as the DOS of the technical component and the read date as the DOS of the professional component. This means that unless your pathologist reads the slides the same day as the biopsy, you will have to start splitting your path claims into separate technical and professional components, with different dates of service for each. (You’ll get paid the same as if you billed the global code.)